INTRODUCTION
g-Aminobutyric acid (GABA) and glycine are the major inhibitory neurotransmitters in the brain (Nemecz et al., 2016) . Glycine receptor (GlyR) and GABA type A receptor (GABA A R) are members of a large Cysloop superfamily and are structurally similar ligand-gated ion channels (Langosch et al., 1990; Jacob et al., 2008) . On activation, the GlyR and GABA A R selectively conduct Cl À through central pores, leading to neuron hyperpolarization and inhibitory neurotransmission in the central nervous system (Nemecz et al., 2016) . These receptors are usually localized at the synapse postsynaptically (Essrich et al., 1998; Langosch et al., 1988) . Emerging evidence has suggested that certain isoforms of GABA A R, including a 5 subunit-containing receptors, can be found pre-synaptically and extra-synaptically (Brickley and Mody, 2012; Castro et al., 2011; Delgado-Lezama et al., 2013; Jia et al., 2005; Hauser et al., 2005) . GlyR is widely distributed in the central nervous system, particularly in the brainstem and spinal cord (Hruskova et al., 2012; Xiong et al., 2014) . To date, four a-subunits (a 1 -4 ) and one b-subunit of GlyR have been identified. All GlyR a subunits can form functional homomeric channels that are mainly located on the pre-and extra-synaptic membrane of a synapse (Hruskova et al., 2012; Xiong et al., 2014; McCracken et al., 2017; Turecek and Trussell, 2001) . However, after co-assembling with the a subunits, the b subunit can form functional postsynaptic heteromeric ab channels (Pribilla et al., 1992; Xiong et al., 2014) .
Hyperekplexia is a human genetic neurological disorder usually caused by point mutations in a 1 GlyRs (Shiang et al., 1993) . Although rare, this disease can be life-threatening in children and is characterized by exaggerated startle response and muscle stiffness following an unexpected stimulus. Numerous point mutations in the GlyR a 1 subunit have been identified and characterized as hyperekplexic mutations disrupting GlyR function (Bode and Lynch, 2014) . Among them, the R271Q was the most common dominant GlyRa 1 mutation identified in patients with hyperekplexia (Thomas et al., 2013) . Despite strong evidence suggesting that the point mutations in the a 1 GlyR are strongly associated with hyperekplexia, the primary therapeutic agent effectively used to treat hyperekplexia in humans is benzodiazepines (Dijk and Tijssen., 2010; Garg et al., 2008; Tijssen et al., 1997) , which selectively enhances GABA A R functioning (Dray and Straughan, 1976; Macdonald and Barker, 1978) . Thus, GABA A Rs seems to be the primary therapeutic target in hyperekplexia. Consistently, a previous investigation revealed a deficiency in both glycinergic and GABAergic transmission in the spinal cord of R271Q mutant mice (Becker et al., 2002; Von Wegerer et al., 2003) . Unfortunately, the cellular and molecular mechanisms underlying the GABA A R deficiency in hyperekplexia remains unclear. Such deficiency is not caused by the posttranslational modification of either GlyR or GABA A R protein since radioligand binding to these receptors was unaffected (Becker et al., 2002) . The speculation that GlyR can cross-talk or interact with GABA A R has been long-standing (Wojcik et al., 2006) . These receptors are abundant in the spinal cord and brainstem where the neurotransmitters GABA and glycine are colocalized and co-released from the same vesicles at many motoneuron synapses (Jonas et al., 1998) . Strong evidence suggests that a substantial proportion of spinal cord inhibitory synapses host both GlyRs and GABA A Rs. Nevertheless, direct evidence and the in vivo consequence of the potential GlyR-GABA A R interaction have not been reported. Considering these questions, we conducted experiments using various approaches to explore the nature of the interaction through which hyperekplexic mutations in the GlyR a 1 subunits disrupt GABA A R functioning at synapses.
RESULTS

GABA A Rs Deficiency in the Brainstem of Hyperekplexic Mutant Mice
To determine whether the hyperekplexic point mutations in the a 1 GlyR could affect GABAergic transmission, we measured GABA release and GABA A R functioning using patch clamp recording in the hypoglossal nucleus slices from two transgenic mouse lines carrying GlyRa 1 R271Q and S267Q hyperekplexic point mutations. Another mouse line carrying GlyRa 1 M287L point mutation was set as a negative control since this mutation was not found in patients with hyperekplexia and has been previously shown to scarcely change the function of GlyR in mice (Bode and Lynch, 2014; Xiong et al., 2014) . Both the frequency and amplitude of GABAergic spontaneous inhibitory postsynaptic currents (sIPSCs) were remarkably attenuated in the hypoglossal nucleus of GlyRa 1 R271Q and GlyRa 1 S267Q but not in GlyRa 1 M287L mutant mice ( Figures 1A and S1 ). Consistently, the electrical stimulation-evoked GABAergic IPSCs (eIPSCs) and the puffing GABA-induced currents were both significantly reduced in the GlyRa 1 R271Q and GlyRa 1 S267Q mutant mice ( Figures 1B and 1C ).
Next, we separately examined the function of GABA A Rs at various synaptic locations including the pre-, post-, and extra-synapses. Here the GlyRa 1 S267Q mice were used as a representative. The frequency but not the amplitude of the GABAergic mIPSCs was significantly decreased in the brainstem hypoglossal nucleus of the GlyRa 1 S267Q mice compared with that in the wild-type (WT) littermates ( Figure 1D ). This suggests that a pre-but not post-synaptic impairment exists in GABAergic transmission. Then, we tested the bicuculline-sensitive tonic current (BSTC), which represents extra-synaptic GABA A R activity. The amplitude of the BSTC was also significantly reduced in the GlyRa 1 S267Q mice compared with that in the WT littermates ( Figure 1E ).
Hyperekplexic GlyRa 1 Mutations Cause GABA A R Deficiency when Co-expressed in HEK-293 Cells
Mutant GlyRs may disrupt the function of GABA A Rs in the same neuron since the preponderance of evidence has indicated a wide colocalization of GlyRs and GABA A Rs in brainstem neurons (Muller et al., 2004 (Muller et al., , 2006 Lorenzo et al., 2006 Lorenzo et al., , 2007 Waldvogel et al., 2019) . Next, we investigated whether the GlyRa 1 mutations could induce GABA A R deficiency if these receptors were co-expressed in HEK-293 cells. Figure 2E ). Interestingly, the other two GlyR a subunits, including a 2 and a 3 , exhibited the same characteristics as a 1 subunit in impairing GABA A R functions. For instance, the point mutations in the GlyRa 2 (R305Q) and GlyRa 3 (R320Q) subunits corresponding to R271Q of GlyRa 1 not only reduced the glycine I max ( Figure 2F ) when expressed alone but also inhibited GABA I max when co-expressed with GABA A Rs ( Figure 2G ).
At high concentrations, GABA can also activate GlyRs ( Figure S2 ) (Singer, 2008) . Thus, we examined the efficacy of muscimol, which is a full agonist specific for GABA A R but not GlyR (Snodgrass, 1978) ( Figure S3A ), in activating GABA A R-GlyR complexes. Consistent with our observation in the above-mentioned E D F 10 -1 10 1 10 2 10 3 10 0 10 4 GABA (μM) 10 -1 10 1 10 2 10 3 10 0 10 4 GABA (μM) Normalized GABA I/Imax Figure 2 . Impairment in GABA A Rs by Hyperekplexic GlyR a 1 Mutations in HEK-293 Cells (A) Representative trace records of glycine I max (up) and GABA I max (down) separately induced by 1 mM glycine and GABA in HEK-293 cells co-expressing GABA A Rs (a 1 b 2 g 2 ) and various hyperekplexic mutant a 1 GlyRs. (B) The average values of glycine I max induced by 1 mM glycine in HEK-293 cells co-expressing GABA A Rs (a 1 b 2 g 2 ) and various hyperekplexic mutant a 1 GlyRs. The data were normalized to the I max of the GlyRa 1 WT group.
(C) Average values of GABA I max induced by 1 mM GABA in HEK-293 cells co-expressing GABA A Rs and various hyperekplexic mutant a 1 GlyRs. The data were normalized to their respective controls (GlyRa 1 WT group).
(D and E) Dose-response curves of I GABA in HEK-293 cells co-expressing GABA A Rs (a 1 b 2 g 2 ) and either WT, a 1 R271Q , a 1 S267Q , or a 1 M287L GlyRs. The data were normalized to I max of the GlyRa 1 WT group (D) or its own group (E).
(F) The average values of glycine I max in HEK-293 cells expressing WT or a 2 R305Q or a 3 R320Q GlyRs.
(G) The average values of GABA I max in HEK-293 cells co-expressing GABA A Rs (a 1 b 2 g 2 ) and WT or a 2 R305Q or a 3
R320Q
GlyRs. All digits within the columns represent numbers of cells measured. Data are represented as mean G SEM. **p < 0.01, ***p < 0.001 based on unpaired t tests; ns, not significant (p > 0.05). experiments using GABA, the amplitude of muscimol (100 mM)-induced maximal current (I max ) was also significantly decreased in HEK-293 cells co-expressing GABA A Rs with GlyRa 1 R271Q or GlyRa 1 S267Q ( Figure S3B ).
The Protein-Protein Interactions between GABA A R and Hyperekplexic Mutant GlyR
First, we investigated whether the hyperekplexic mutations will affect the membrane trafficking of GlyR and GABA A R. The western-blotting results showed that both the S267Q and R271Q point mutations in the GlyRa 1 subunit did not affect the protein expression level of GlyR or GABA A R in plasma membranes extracted from HEK-293 cells co-transfected with the cDNA of GlyRa 1 WT , GlyRa 1 R271Q , and GlyRa 1 S267Q with or without GABA A Rs ( Figure S4 ).
A possible mechanism of the GABA A R deficiency in the presence of mutant GlyRs is that there may exist an interaction between GlyR and GABA A R proteins. To test this hypothesis, we conducted a co-immunoprecipitation (Co-IP) assay of mutant or WT GlyRa 1 subunits and GABA A Rs (a 1 b 2 g 2 ) co-expressed in HEK-293 cells. The point mutations R271Q and S267Q, but not M287L, significantly increased the amount of GlyR protein co-immunoprecipitated with GABA A R proteins from whole cell lysates ( Figures 3A, S5 , and S6) and plasma membrane preparations ( Figure S7 ). Similar results were observed in vivo in transgenic mice carrying GlyRa 1 mutations. The association between the GlyRs and GABA A Rs was remarkably enhanced in the brainstem of the GlyRa 
The Site R271 Is Critical for the Interaction between GABA A R and Hyperekplexic Mutant GlyR
Subsequently, we conducted a molecular dynamic simulation to evaluate the interaction between the subunits of GABA A Rs and hyperekplexic mutant GlyR subunits in Figure 3 . Identification of Interaction between GABA A R and Hyperekplexic Mutant GlyRs (A) GlyRa 1 was purified using GABA A R a 1 antibodies in HEK-293 cells co-expressing GABA A Rs (a 1 b 2 g 2 ) and WT/mutant a 1 GlyRs, and the co-precipitating proteins were detected by immunoblotting. Inputs are immunoblots of the same protein in cell lysates before Co-IP. Quantification of WT and mutant GlyR a 1 binding to GABA A R a 1 subunits (n = 3). The data were normalized to the WT group.
(B and C) Endogenous brainstem GlyRa 1 of WT and GlyRa 1 R271Q (B) or S267Q (C) KI mice was purified using GABA A R a 1 antibodies, and the co-precipitating proteins were detected by immunoblotting. Inputs are immunoblots of the same protein in tissue lysates before Co-IP. Quantification of WT and R271Q (B) or S267Q (C) mutant GlyRa 1 binding to GABA A Ra 1 (n = 3 mice). (D) Endogenous brainstem GlyRa 1 of WT and GlyRa 1 M287L KI mice was purified using GABA A R a 1 antibodies, and the coprecipitating proteins were detected by immunoblotting. Inputs are immunoblots of the same protein in tissue lysates before Co-IP. Quantification of WT and M287L mutant GlyRa 1 binding to GABA A Ra 1 (n = 3 mice). The data were normalized to the WT group. (G) GlyRa 1 was purified using GABA A R a 1 antibodies in HEK-293 cells co-expressing GABA A Rs (a 1 b 2 g 2 ) and GlyRa 1 carrying various R271 mutations, and the co-precipitating proteins were detected by immunoblotting. Inputs are immunoblots of the same protein in cell lysates before Co-IP. Quantification of WT and R271 mutant GlyRa 1 binding to GABA A R a 1 (n = 3). Data were normalized to the WT group. different combinations of dimers. First, all simulations were reliable since no unexpected collapse of protein structures were observed ( Figure S9 ). Then, the binding affinities between the subunits in the dimers, including GABA A R homer-dimers (GB/GB) and GABA A R bound with GlyR (GB/GR) or GlyR mutant (GB/GRM), were analyzed and compared. Among the WT receptor combinations, two subunits in the GB/GB complex showed the strongest binding affinity with a binding free energy (BFE) of À121.9 G 4.3 kcal/mol. However, the binding affinities in the GB/GR complex were much weaker (À89.2 G 8.9 kcal/mol). A significant decrease in BFE was observed between the subunits in GB/GRM (Figure 4B) . Notably, the BFE value in GB/GRM was as low as À123.4 G 14.3 kcal/mol, which is highly similar to the value observed in GB/GB. Further analysis indicates that the mutation of R271Q may lead to hydrogen bonding with TYR227 instead of GLN231 on GABA A R ( Figure 4A ). The R271Q mutation promotes a conformational change in the GB and GR subunits, leading to more intensive H-bond formation and a larger contact surface area between the subunits ( Figures 4C and 4D ).
To obtain further molecular insight into the role of site R271 in the association between GABA A Rs and GlyRs, we used mutagenesis to analyze the interrelationship between the function of GABA A Rs and the biophysical properties of the amino acid residue at 271 of the GlyRa 1 . The mutation-induced decrease in glycine I max ( Figure S10A ) and GABA I max ( Figure 4E ) varied substantially. No correlation was observed between the percentage inhibition of glycine I max and that of GABA I max ( Figure S10B ), suggesting that the dysfunction in GABA A R does not depend on the efficacious levels of GlyRs. Then, to examine the biophysical properties of the amino acid residue at 271 of the GlyRa 1 , we performed a comparative molecular similarity index analysis (CoMSIA), which is a comprehensive method evaluating polarity, electrostatic potential, and steric property. A strong correlation was observed between the CoMSIA values of various amino acids at 271 and the function of GlyRs ( Figure S10C ) or GABA A Rs ( Figure 4F ). Combined with the results of the molecular dynamics simulation, the R271Q point mutation likely suppresses the function of GlyR by altering the protein conformational change required for channel gating. This point mutation also disrupted GABA A R functioning by enhancing the interaction between GlyR and GABA A R. To further test this hypothesis, we performed a Co-IP assay to examine the interaction between the mutant R271E/L/K/G a 1 GlyRs and GABA A Rs co-expressed in HEK-293 cells. Both the GlyRa 1 subunits and GABA A Ra 1 subunits were identified in the co-immunoprecipitants pulled down by the GABA A Ra 1 antibodies (Figures 4G and S11A-S11C). Among the four GlyRa 1 R271 mutations, the R271L and R271E mutations appeared to enhance the binding of GlyR to GABA A R. The protein levels of GlyRa 1 R271X bound to GABA A Ra 1 were significantly and positively correlated with the extent of the GABA A R deficiency, although their levels substantially varied ( Figure 4H ).
GlyR b Subunits Restore Dysfunction of GABA A Rs Caused by GlyR a 1 Mutations
The above-mentioned results have suggested that the pre-and extra-but not post-synaptic GABA A Rs were impaired in hyperekplexia disease. It is worth mentioning that GlyR homomers (a/a) have been found to primarily reside at pre/extra-synaptic sites, whereas GlyR heteromers (a/b) are mostly post-synaptic (Betz et al., 1991; Hruskova et al., 2012; Xiong et al., 2014; McCracken et al., 2017; Turecek and Trussell, 2001) . Thus, a possible scenario is that different combinations of GlyR subunits may have distinct abilities to interact with GABA A Rs. To test this hypothesis, we performed the electrophysiological experiments and Co-IP assay. Addition of the GlyR b subunit indeed prevents the hyperekplexic point mutations in the a 1 subunit from hijacking the GABA A Rs because no functional disruption in the GABA A R was observed after co-expressing the GlyR b subunits with the GlyRa 1 R271Q /GABA A R complexes in HEK-293 cells (Figures 5A and 5B) . Furthermore, the GlyR b subunits also significantly interrupted the association between the mutant a 1 GlyRs and GABA A Rs in HEK-293 cells (Figures 5C and S12). These observations may hint at why only preand extra-synaptic GABA A Rs have been impaired in hyperekplexia.
Colocalization and Interaction of a 5 -Containing GABA A Rs and Hyperekplexic Mutant GlyRs
Emerging evidence suggests that a 5 subunits-containing GABA A R (a 5 b x g x ) is the primary form of pre-and extra-synaptic GABA A Rs in several brain regions, including the hippocampus, spinal cord, and brainstem ( of a 5 -containing GABA A receptor could also cause severe convulsive seizure (Galanopoulou, 2008) . Here, using RNAscope techniques, we conducted in situ hybridization and observed a high degree of colocalization of GlyRa 1 and GABA A Ra 5 subunit mRNAs in neurons in the hypoglossal nucleus of the brainstem in both the GlyRa 1 S267Q and WT mice ( Figures 6A, 6B , and S13). Therefore, we next examined whether the hyperekplexic mutant GlyRs could also affect the a 5 -containing GABA A Rs. The GABA I max was significantly decreased when the a 1 S267Q mutant GlyRs were co-expressed with a 5 b 2 g 2 GABA A Rs in HEK-293 cells ( Figure 6C ). Compared with the WT, the S267Q point mutation significantly increased the amount of GlyRs co-immunoprecipitated with a 5 b 2 g 2 GABA A Rs in both the HEK-293 cells (Figures 6D and S14A-S14C) and the brainstem of GlyRa 1 S267Q mutant mice (Figures 6E and S14D-S14F).
Pre-and Extra-synaptic a 5 -Containing GABA A R Is a Therapeutic Target of Diazepam for Hyperekplexia Disease
Benzodiazepines (BZDs) have always been used as the first-line medication to treat patients with hyperekplexia in the clinic (Dijk and Tijssen, 2010; Garg et al., 2008; Tijssen et al., 1997) . Therefore, we next assessed whether diazepam (DIA), the most common BZD, could rescue the pre-and extra-synaptic GABA A R deficiency in the brainstem hypoglossal nucleus of GlyRa 1 S267Q KI mice. We conducted the following electrophysiological recordings, Co-IP experiments, and behavioral tests using homozygous and heterozygous GlyRa 1 S267Q KI mice because most GlyRa 1 R271Q KI mice died within 2-3 weeks ( Figure S15 ). DIA significantly rescued the reduced frequency of GABA mIPSCs ( Figure 7A ) and the attenuated amplitude of the BSTC ( Figure 7B ) in the brainstem hypoglossal nucleus of the GlyRa 1 S267Q mutant mice. Consistently, DIA also significantly restored the attenuated GABA I max in HEK-293 cells co-expressing a 5 -containing GABA A Rs and a 1 S267Q GlyRs ( Figure S17A ). These effects of DIA were remarkably diminished by Xli-093 ( Figures 7A   and 7B ), which could specifically block DIA-induced potentiation on a 5 -( Figure S16 ) but not a 1 /a 2 -containing GABA A Rs (Clayton et al., 2015) (Figures S17B and S17C).
Next, we investigated whether the restoration of pre-and extra-synaptic GABA A R functioning by DIA in the brainstem hypoglossal nucleus was sufficient to treat hyperekplexia. An intraperitoneal (i.p.) injection of DIA markedly alleviated hind feet clenching behaviors and exaggerated tremors in the GlyRa 1 S267Q KI mice when the animals were picked up by their tails ( Figure 7C ). The therapeutic effect of DIA was completely abolished by an intra-brainstem hypoglossal nucleus microinjection of Xli-093 ( Figure 7C ). The GlyRa 1 S267Q mutant mice displayed exaggerated startle reflexes in response to various acoustic stimuli ( Figure 7D ). The systemic administration of DIA significantly inhibited the exaggerated startle responses of the GlyRa 1 S267Q KI mice. This DIA therapeutic effect was remarkably suppressed by an intra-brainstem hypoglossal nucleus injection of Xli-093 ( Figure 7E ). The startle reactions of the WT and various hyperekplexic mutant mice were significantly correlated with their brainstem hypoglossal nucleus presynaptic GABA A Rs deficiency (expressed as percentage decreases in mIPSC frequency) and the bonding strength between the GlyR and GABA A R (expressed as normalized GlyR-GABA A R CO-IP) ( Figure 7F ). Altogether, our results S267Q M287L 0.0 0.5 Figure 5 . GlyR b Subunits Restore GABA A Rs Functioning by Interrupting the Interaction between GABA A Ra 1 and GlyRa 1 Subunits (A) Average glycine I max values in HEK-293 cells co-expressing GABA A Rs (a 1 b 2 g 2 ) and either homomeric or heteromeric hyperekplexic mutant a 1 /b GlyRs. (B) Average GABA I max values in HEK-293 cells co-expressing GABA A Rs (a 1 b 2 g 2 ) and either homomeric or heteromeric hyperekplexic mutant a 1 /b GlyRs. (C) GlyRa 1 was purified using GABA A R a 1 antibodies in HEK-293 cells co-expressing GABA A Rs (a 1 b 2 g 2 ) and homomeric or heteromeric hyperekplexic mutant a 1 /b GlyRs, and the co-precipitating proteins were detected by immunoblotting. Inputs are immunoblots of the same protein in cell lysates before Co-IP. Quantification of WT and mutant GlyRa 1 binding to GABA A R a 1 (n = 3). Data were normalized to the WT group. All digits within the columns represent numbers of cells measured. Data are represented as mean G SEM. *p < 0.05, **p < 0.01, ***p < 0.001 based on unpaired t tests; ns, not significant (p > 0.05).
reveal that the pre-and extra-synaptic a 5 -containing GABA A R may be the major acting target of BDZ to treat hyperekplexia disease.
DISCUSSION
Both GABA A R and GlyR mediate rapid synaptic transmissions in the central nervous system (Jacob et al., 2008; Langosch et al., 1990) . Despite the widespread speculation that cross talk exists between these two types of receptors (Schmieden et al., 1993; Shrivastava et al., 2011; Maric et al., 2011) , knowledge regarding the nature of such an interaction is limited. The data presented in this study provided several lines of evidence that primary hyperekplexic point mutations in the GlyR a 1 subunit can suppress GABA A R functioning by hijacking GABA A Rs via protein interaction both in vitro and in vivo. This interaction underlies the pathological mechanism of hyperekplexia (Figure 8) . First, hyperekplexic mutations in GlyR a 1 subunits impair the functioning of both GlyRs and GABA A Rs in HEK293 cells and the mouse brainstem hypoglossal nucleus. Second, the mutant GlyRs are highly capable of forming hetero-oligomers with certain types of GABA A Rs. The R271Q point mutation increased the binding free energy, contact surface area, and number of hydrogen bonds between GABA A Ra 1 and GlyRa 1 protein. Third, the signal intensity of such GlyR-GABA A R complexes is highly correlated with the severity of the GABA A R deficiency and exaggerated startle responses in hyperekplexic mice. (B) Left, percentage of GlyRa 1 mRNA-positive neurons that co-express GABA A Ra 5 mRNA. Right, percentage of GABA A Ra 5 mRNA-positive neurons that co-express GlyRa 1 mRNA (n = 3 mice).
(C) Trace records and average values of GABA I max activated by 1 mM GABA in HEK-293 cells co-expressing GABA A Rs (a 5 b 2 g 2 ) and WT or a 1 S267Q mutant GlyRs. The digits within the columns represent numbers of cells measured.
(D) GABA A Ra 5 was purified using GlyRa 1 antibodies in HEK-293 cells co-expressing GABA A Rs (a 5 b 2 g 2 ) and WT/S267Q mutant GlyRa 1 , and the co-precipitating proteins were detected by immunoblotting. Inputs are immunoblots of the same protein in cell lysates before Co-IP. Quantification of GABA A R a 5 binding to WT and S267Q mutant GlyR a 1 (n = 3 mice). (E) Endogenous brainstem GABA A R a 5 in WT and GlyRa 1 S267Q KI mice were purified using GlyRa 1 antibodies, and the co-precipitating proteins were detected by immunoblotting. Inputs are immunoblots of the same protein in tissue lysates before Co-IP. Quantification of mouse brainstem GABA A R a 5 binding to WT and S267Q mutant GlyR a 1 (n = 3 mice). Data are represented as mean G SEM. **p < 0.01, ***p < 0.001 based on unpaired t tests; ns, not significant (p > 0.05).
In this study, weak binding between the WT GlyRs and GABA A Rs was observed in both the HEK-293 cells and brainstem tissues. This weak bonding is unlikely to affect the functioning of both ion channels because the glycine and GABA-activated currents did not show differences when the WT GlyRs and GABA A Rs were either separately expressed or co-expressed in the HEK-293 cells. In contrast, this weak binding may provide a possible explanation for the synergistic effects of glycine and GABA that have been observed in several previous reports (Li and Yang, 1998; Rogers et al., 2016) . For instance, a strong synergistic interaction has been observed between GABA and glycine in acutely isolated crucian carp retina neurons. The coapplication of both agonists resulted in much larger responses (current >400 pA) than either GABA or glycine alone (current <20 pA) (Li and Yang, 1998) . Another report also demonstrated that GABA and glycine can act synergistically at the spinal cord to generate a tonic inhibition of the micturition reflex pathway (Rogers et al., 2016) . However, such bonding between GlyR and GABA A R does not appear to always be a good thing. In fact, the hyperekplexic mutations in GlyR caused stronger binding with GABA A R but remarkably impaired the functioning of both channels.
Site mutations generally attenuate the interaction between two associated proteins (Salpietro et al., 2019; Smets et al., 2017; Bizarro and Meier, 2017) . However, our findings reveal an entirely opposite pattern in the modulation of protein-protein interactions, particularly under pathological conditions. For instance, several hyperekplexic site mutations in GlyR a 1 , such as R271Q and S267Q, enhance its bonding interaction with GABA A R and therefore induce dysfunction in GABA A R. This mechanism may be universal since a similar pattern has been observed in several previous studies investigating the molecular and cellular mechanisms of various diseases. For instance, the R882H mutation in DNA (cytosine-5-)-methyltransferase 3a (DNMT3A) enhances its binding to polycomb repressive complex 1 (PRC1) protein and causes transcriptional silencing, suggesting that PRC1 favors R882 mutants over WT as binding partners in DNMT3A-mutated leukemia disease (Koya et al., 2016) . Furthermore, the H443P mutant NOD-like receptor (NLR) protein NLRC4 more strongly interacts with 19S proteasome ATPase Sug1 and ubiquitinated proteins in auto-inflammatory syndrome. This enhanced interaction triggers the constitutive caspase-8-mediated cell death (Raghawan et al., 2017) .
The hijacking of GABA A Rs by mutant GlyRs also results in a deficiency in major inhibitory neurotransmission. This finding is consistent with a previous study showing that the R271Q point mutation causes the hyperekplexia phenotype and impairs glycine and GABA transmission in mice (Becker et al., 2002; Von Wegerer et al., 2003) . The GlyR b subunit greatly reduces the formation of the GlyR-GABA A R complex, suggesting that the hijacking of the GABA A R by the mutant GlyRa 1 subunits likely occurs in pre-or extra-synaptic sites where the GlyR b subunit is absent. Consistently, the low levels of the GlyR b subunit were associated with the hyperekplexic phenotype in mice (Becker et al., 2000) . This hypothesis was tested and supported by the subsequent electrophysiological recordings, which indicated that only pre-and extra-synaptic GABA A Rs were impaired in the brainstem hypoglossal nucleus of hyperekplexic mice. Therefore, this study reveals that the pre-and extra-synaptic GABA A Rs, specifically the a 5 subunit-containing GABA A Rs primarily located in brainstem hypoglossal nucleus, are novel primary targets in hyperekplexia. This hypothesis is supported by our finding that the GABA A Ra 5 and GlyRa 1 subunits are colocalized in the brainstem hypoglossal nucleus in GlyRa 1 S267Q and WT mutant mice as revealed by RNAscope technology. DIA, which has been widely used to treat hyperekplexia in the clinic (Garg et al., 2008; Becker et al., 2000; Tijssen et al., 1997) , indeed specifically rescued the deficiency of pre-and extra-synaptic a 5 -containing GABA A Rs in the HEK-293 cells and mouse brainstem hypoglossal nucleus and restored the exaggerated startle reflex behaviors in the hyperekplexic mutant mice. Thus, developing specific GABA A Ra 5 agonists or modulators may be critical for the treatment of hyperekplexia without producing the major psychoactive or sedative side effects that are associated with benzodiazepines, such as DIA. Such dynamic changes in pre-and extra-synaptic GlyR-GABA A R complexes may also contribute to various physiological and pathological processes, such as pain, anxiety, and sleep disorders (Botta et al., 2015; Bravo-Hernandez et al., 2016; Crestani et al., 2002; Xiong et al., 2011 Xiong et al., , 2012 . Thus, this GlyR-GABA A R interaction not only leads to human hyperekplexia but also may contribute to various neurological disorders involving GlyR and GABA A R deficiency.
Limitations of the Study
Although we identified the interaction between GlyR and GABA A R in the brain of hyperekplexic transgenic mice, the detailed interaction pattern and interaction sites between both receptors remain unsolved in the present study. Future research should consider utilizing more advanced molecular biology approaches to clarify the detailed mechanisms involved.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
The raw data that support the findings of this study are available from the corresponding authors, upon request.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.08.018. Figure S1 . Trace records, average frequency and amplitude of GABAergic sIPSCs in brainstem hypoglossal nucleus slices from WT and GlyRα1 M287L mutant mice (related to Figure  1) . All digits within the columns represent numbers of cells measured. Data are represented as mean ± SEM. ns, not significant (P > 0.05) based on unpaired t-tests. Figure S2 . GABA-activated currents on GlyRs (related to Figure 2) . Average values of currents activated by 1 mM GABA in HEK-293 cells expressing WT and mutant α1 GlyRs. All digits within the columns represent numbers of cells measured. Data are represented as mean ± SEM. ns, not significant (P > 0.05) based on unpaired t tests. Figure S4. (related to Figure 3) . Western blotting results showing protein expression levels of GlyR and GABAAR in plasma membranes extracted from HEK-293 cells co-transfected with the cDNA of GlyRα1 WT , GlyRα1 R271Q and GlyRα1 S267Q with GABAARs (α1β2γ2). ns, not significant (P > 0.05) based on unpaired t tests. Figure S5. (related to Figure 3) . The GABAARα1 was purified using GlyRα1 antibodies in HEK-293 cells co-expressing GABAARs (α1β2γ2) and WT/mutant GlyRα1, and co-precipitating proteins were detected by immunoblotting. Inputs are immunoblots of the same protein in cell lysates prior to co-IP. Quantification of WT and mutant GlyRα1 binding to GABAARα1. All digits within the columns represent numbers of cells measured. Data are represented as mean ± SEM. * P < 0.05, *** P < 0.001; ns, not significant (P > 0.05) based on unpaired t tests. Figure S7 . Identification of association between mutant GlyRα1 and GABAARα1 in the plasma membrane (related to Figure 3) . Plasma membrane GlyR α1 was purified using GABAAR α1 antibodies in HEK-293 cells co-expressing GABAARs (α1β2γ2) and WT/mutant α1 GlyRs, and the co-precipitating proteins were detected by immunoblotting. Quantification of WT and mutant GlyR α1 binding to GABAAR α1 (n = 3). The data were normalized to the WT group. Data are represented as mean ± SEM. * P < 0.05, *** P < 0.001 based on unpaired t tests. Figure S8 . Whole gel images for Figure 3B (A-C) ; whole gel images for Figure 3C (D-F) and whole gel images for Figure 3D (G-I) (related to Figure 3 ). Figure S9 . Root mean square fluctuation (RMSF) of three protein systems with respect to the starting structure (related to Figure 4) . (A-C) Preparation and Molecular dynamic simulation of three protein bound systems. Protonation status of residues in three systems: Four histidine residues (His107, His 119, His 191 and His267 in chain A) and four histidine residues (His107, His 119, His 191 and His267 in chain B) were protonated at Nε in GB/GB system. Four histidine residues (His107, His 119, His 191 and His267 in chain A) and three histidine residues (His109 , His 201 and His215 in chain B) were protonated at Nε in GB/GR system. Four histidine residues (His107, His 119, His 191 and His267 in chain A) and three histidine residues (His109 , His 201 and His215 in chain B) were protonated at Nε in GB/GRM system. All other residues were configured under the standard protonation states at pH 7. The optimization of the solvent, equilibration of the whole systems and the molecular dynamic simulation of the equilibrated systems were conducted following the steps listed below: After applying a position restraint of 100 mol−1 Å−2 on all solute atoms, solvent and ions were optimized by three steps: a. energy minimization for 1000 cycles; b. dynamic simulation of 10ps with the temperature increased from 10K to 298K; c. dynamic simulation of 10ps under pressure of 1 bar to equilibrate the density. After applying a restraint weight of 2.0 mol−1 Å−2 on proteins, the whole systems were equilibrated. First, 1000 cycles of energy minimization were applied. Second, the temperature was increased from 10K to 298 K over a period of 5ps dynamic simulation. Third, a dynamic simulation of 200ps under the constant pressure of 1 bar was applied. Finally, the whole system was equilibrated by 100ps dynamic simulation under constant temperature of 298 K and pressure of 1 bar. 1 ns MD production simulations were carried out under the constant temperature and pressure of 298K and 1 bar. Periodic boundary conditions were applied in the NPT ensemble using langevin dynamics. The SHAKE algorithm was applied to fix all bond lengths involving hydrogen atoms. A time step of 2 fs and a direct non-bond interaction cut off radius of 8.0 Å were used with particle-mesh Ewald for long-range electrostatic interactions. Three parallel runs were carried out for each system. Residues used for 3D-QSAR analysis were generated in SYBYL8.1 software. The structures were minimized and charged with MMFF94 force field. Comparative molecular similarity index analysis (CoMSIA) was conducted to model the correlation between residues structures and inhibition activity. Both electrostatic field and steric field were generated. Final computed CoMSIA value of residues were plotted with inhibition activity. n =10 n =11 n =10 n =15 n =15 n =12 n =13 n =12 n =13 n =13 n =8 n =10 n =15 n =8 n =10 n =9 n =10 n =13 n =12 n =16 Figure S11 . Whole gel images for Figure 4G (related to Figure 4) . 
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Transparent Methods
Animals.
GlyRα1 S267Q and GlyRα1 M287L transgenic mice were from Yuri Blednov and Adron Harris (University of Texas at Austin, Texas) (Findlay et al., 2003; Borghese et al., 2012) .
GlyRα1 R271Q transgenic mice were from Hans Weiher (University of Applied Sciences
Bonn-Rhein-Sieg, Germany) (O'Shea et al., 2004) . Hyperekplexic GlyR mutant mice and their wild-type littermates (P12-P21) were used in all recording, western blot and co-immunoprecipitation experiments. Hyperekplexic GlyR mutant mice and their wildtype littermates (7-8 weeks old) were used in startle reflex and RNAscope tests. All mice were housed under a semi-natural dark/light cycle of 12:12 h. All genetically engineered mice studied were homozygous and heterozygous for the mutant α1 subunit.
Genotyping of the α1 M287L mutant mice was done using the following primers: forward: 5′-GAATCTTCCAGGCAACATTTCAG-3′; reverse: 5′-AGTATCCCACCAA-GCC AGTCTTT-3′. Genotyping of the α1 S267Q mutant mice were done using the Site-directed mutagenesis.
All point mutations for α1-3 GlyR were introduced using a QuikChange Site-Directed Mutagenesis kit (Takara, Inc.). Sequence of DNA mutants were confirmed through double-stranded DNA sequencing with Genetic Analysis System (Sangon, Inc.).
Electrophysiological recording.
HEK-293 cells (ATCC) were cultured using Dulbecco`s Modified Eagle Media with 10 % fetal bovine serum in 37°C and 5 % CO2. Cells were plated at a density of 10 6 cells/ml in 35-mm dishes and allowed to grow to 70 % confluence before transfection (Hu et al., 2006) . Plasmids coding GABAA R and GlyR were co-transfected into HEK- software (Molecular Devices, Sunnyvale, CA). Drugs were applied using a Warner faststep stepper motor-driven system.
Brainstem hypoglossal nucleus slice preparation and recording.
For brainstem slice neuron recording, hyperekplexic GlyR mutant mice and their wildtype littermates (P12-P21) were used. Brainstem slices were prepared as followings:
parasagittal brainstem slices (260-μm thick) were prepared from P12 to P21 mice with Leica Vibratome in ice-cold cutting solution containing (in mM) 30 NaCl, 26 NaHCO3, 10 glucose, 194 sucrose, 4.5 KCl, 1.2 NaH2PO4, 1 MgCl2 and continuously bubbled with carbogen (95 % O2-5 % CO2). Slices were transferred to a perfusion chamber containing artificial cerebrospinal fluid (ACSF) (in mM): 124 NaCl, 4.5 KCl, 1 MgCl2, 2
CaCl2, 1.2 NaH2PO4, and 26 NaHCO3, continuously bubbled in carbogen. After 60 min recovery at room temperature, slices were transferred to a recording chamber continuously perfused with ACSF (2-3ml/min). All recordings were performed at 34 °C using glass pipettes filled with internal solution containing 120 mM CsCl, 4 mM MgCl2, 10 mM EGTA, 10 mM HEPES, 0.5 mM Na-GTP and 2 mM Mg-ATP (pH 7.2 with CsOH, ~280 mOsm). For sIPSCs recording, 4 mM kynurenic acid and 1 μM strychnine were added in continuously perfused ACSF solution. For mIPSCs recording, 10 μM TTX was additionally added in continuously perfused ACSF. Maximum current of GABAARs induced by 1mM GABA was recorded in brainstem slices of GlyRα1 mutant mice and littermate wild type mice. Extra-synaptic current of GABAARs was recorded with bicuculline. 80 μM bicuculline,10 μM Diazepam and 1 μM Xli-093 was applied by puff application directly to the recorded neuron using a positive pressure system (4 PSI, 15 ms; Toohey Company, Fairfield, NJ). The input resistance was monitored continuously, and the recording was abandoned if the resistance changed more than 15 %.
All brainstem slice recordings were performed under a double-blind condition.
Computational investigation of three protein bound systems.
Three protein bound systems were prepared to investigate the binding affinity between GABAAR and GlyR. Crystal structures of protein GABAAR β3 obtained at a 2.7 Å resolution of GlyR is mutated to Glutamine. The initial binding conformation of the GB/GR complex was obtained using Z-dock software (Pierce et al., 2014) .
All crystallographic water molecules and ligands were removed. The protonation states were investigated using the H++ Server (Anandakrishnan et al., 2012) (protonation status is listed in Supporting Information). The protein was charged using an AMBER ff12SB force field. The proteins were solvated in a rectangular box of TIP3P water with a minimum distance between the protein and the box edge of 11 Å. The initial density of the systems was set as 0.9 g·mL −1 .
The optimization of the solvent, equilibration of the whole systems and the molecular dynamic simulation of the equilibrated systems were conducted in all three systems.
The trajectory was sampled every 1 ps for the analysis using the ptraj and cpptraj programs. The protein structures and snapshots were visualized using VMD (Humphrey et al., 1996) . The RMSF values of the protein systems were calculated after aligning to the first structure during the entire 1 ns. Using the MM/GBSA (Molecular Mechanics/Generalized Born Surface Area) method, the binding free energy of two chains was calculated during the entire simulation time. The distances between the residue and atom pairs were obtained using the WORDOM program (Seeber et al., 2007) and mapped using the Gnuplot program (http://www.gnuplot.info/).
Western blotting.
The GlyR and GABAAR plasmids were transfected into HEK-293 cells using lipo2000 
Co-Immunoprecipitation.
The cell lysates were collected using methods similar to those used for the Western blotting. To show whether there is any change in protein expression level, 60 µL cell or tissue lysates was extracted and mixed with same volume loading buffer as input before immunoprecipitation. The "input" always performed as a necessary control in all coimmunoprecipitation experiments. IgG-agarose beads were incubated with primary antibodies against GABAAR α1 or GlyR α1 protein overnight at 4°C. The mixture was washed and centrifuged 5 times for 1 min at 12,000 rpm with PBS. The samples were collected, and the centrifugal mixture with the cell lysates was blended and then incu- The other procedures were consistent with those used for the HEK-293 cells.
RNAscope method.
For RNAscope tests, hyperekplexic GlyR mutant mice and their wild-type littermates (7-8 weeks old) were used. Whole brain tissues were removed and frozen on dry ice.
The fresh frozen tissue sections (12 µm thick) were mounted on positively charged microscopic glass slides (Thermo Fisher Scientific, Waltham, MA). Both the GlyRα1 The synthesis of Xli-093.
Xli-093 were synthesized according to a previous study (Li et al., 2003) as shown in the following steps. A solution of carbonyldiimidazole (90.7 mg, 0.56 mmol) and 8ethynyl-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[l,5-a][l,4]-benzod iazepi-ne-3-carboxylic acid (148.9 mg, 0.53 mmol) in anhydrous DMF (10 mL) was stirred for 3 h at room temperature. After the starting material was converted by TLC (silica gel), to the solution was then added 1,3-propanediol (21.3 mg, 0.28 mmol) and DBU (102.1 mg, 0.67 mmol) in dry DMF (1 mL). The mixture was stirred at room temperature over night until the reaction was complete by TLC (silica gel). The reaction mixture was then poured into water (60 mL) and extracted with DCM (3 × 50 mL). The combined organic layer was washed with water (50 mL), brine and dried with Na2SO4. The solution was filtered and the filtrate was condensed. The residue was purified by flash chro- 
Drugs.
Most chemicals including GABA and glycine were achieved from Sigma-Aldrich. All solutions were prepared the day before experiment with ultrapure water. Agonist, modulator and antagonist were diluted before experiment with external solution or ACSF.
Diazepam and Xli-093 was dissolved in ethanol before further dilution by external solution. Diazepam was sourced from Sigma-Aldrich. All the final concentration of ethanol in working solution was less than 8 mM, which had no potential effect on IGly and IGABA. All the vehicles used in experiments had no latency responses when used alone.
Startle reflex test.
The mice were placed in Med Associates Startle Reflex System (Med Associates Inc.) chambers and allowed to habituate for 5 min. Then, the mice were tested to measure their level of startle using a series of pseudorandom white noise startle stimuli (10 presentations of each sound intensity, 85 dB, 90 dB, and 95 dB) with a 58-63 s intertrial interval (ITI). Male heterozygous S267Q transgenic mice and their wild-type littermates (7-8 weeks old) were used in the startle test. The mice were injected with diazepam (10 mg/kg, i.p.) and Xli-093 (5 µg/2 µL, intra-brainstem hypoglossal nucleus.) before being placed in the startle device.
Statistical analysis.
In our study, no statistical methods were used to predetermine sample sizes, all experiments and data analysis were conducted in a blinded way. For behavioral experiments, animals from different genotypes were picked randomly for testing. , Imax is the maximum response of the cell, and EC50 is the concentration eliciting a half-maximal response. Correlation analysis were performed with linear regression. Data were statistically compared by unpaired t test using GraphPad Prism 6.0 (GraphPad Software), as indicated in the specific figure legends. Average values are expressed as the mean ± SEM and mean ± SD. P < 0.05 was considered significant. The data distribution was assumed to be normal, but this was not formally tested.
